Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to investigate the efficacy and safety of tolvaptan based on the change in serum sodium concentration following administration of tolvaptan oral tablets at 7.5 to 60 mg/day for up to 30 days in patients with hyponatremia in the SIADH.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03048747
Study type Interventional
Source Otsuka Pharmaceutical Co., Ltd.
Contact
Status Completed
Phase Phase 3
Start date March 2, 2017
Completion date March 19, 2019